Fig. 6From: Vaccinomic approach for novel multi epitopes vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)Solubility of the vaccine construct as obtained by protein sol server. The solubility of the vaccine construct was shown to be 0.571 compared to 0.45 of the population average solubility of E. coliBack to article page